DDPG in the news
In response to the recent Pfizer takeover bid for Astrazeneca the DDPG released a
letter that highlighted the changing drug discovery landscape in the UK and the effects on the science community. This led to considerable media interaction.
Representatives of the DDPG published
Research Fortnight article written by David Phillips: Big pharma is broken, how can we fix it?
Research Fortnight article written by David Fox from the RSC: Keep making the tablets.
Research Fortnight article written by Mark Downs, chief executive of the Royal Society of Biology, Drug discoverers must adapt to a more complex world.
Comments from Mark Downs, chief executive of the Royal Society of Biology, recently featured in the Nature article
AstraZeneca juggernaut heads for Cambridge (£ – pay to view).